[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hyperthyroidism-autoimmune\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hyperthyroidism-autoimmune":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":15,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":26,"conditions":27,"keywords":4,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100623714","phase-1-clinical-application-of-al18f-nota-fapi-04-petct-or-petmri-imaging-in-malignant-tumorcardiovascular-or-immune-disease-100623714",false,"NCT07400224","Clinical Application of Al18F-NOTA-FAPI-04 PET\u002FCT or PET\u002FMRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease","Inclusion Criteria:\n\n* a. Age 18 years old or above, gender not restricted. b. Have undergone a health check-up within the last 3 months (at least completed chest X-ray \u002F chest CT and abdominal B-ultrasound and other examinations), and no major diseases were found.\n\nExclusion Criteria:\n\n* As this study involves certain radiation exposure, patients who have had frequent radiation exposure due to clinical needs (those who have undergone a CT or PET\u002FCT examination once within 3 months or 1 month respectively) are not included in the study.",true,"ALL","18 Years","88 Years",{"count":20,"type":21},600,"ESTIMATED","INTERVENTIONAL",[24,25],"PHASE1","PHASE2","This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinical treatment strategy guidance.",[28,29,30],"Hyperthyroidism, Autoimmune","Cardiovascular Abnormalities","Malignant Tumor","RECRUITING","2026-02-03",{"date":34,"type":35},"2026-02-10","ACTUAL",{"date":37,"type":35},"2022-05-10",{"date":39,"type":21},"2028-12-31",{"name":41,"class":42},"Peking Union Medical College Hospital","OTHER"]